PMID- 24309024 OWN - NLM STAT- MEDLINE DCOM- 20150406 LR - 20140120 IS - 1769-6682 (Electronic) IS - 1297-9589 (Linking) VI - 42 IP - 1 DP - 2014 Jan TI - [Role of imaging procedures in the diagnosis of synchronous bilateral breast cancer]. PG - 14-9 LID - S1297-9589(13)00230-0 [pii] LID - 10.1016/j.gyobfe.2013.08.004 [doi] AB - OBJECTIVE: To investigate the role of imaging procedures in the diagnosis of synchronous bilateral breast cancer (SBBC) PATIENTS AND METHODS: The patient group consisted of consecutive women undergoing managed for SBBC in our institution between January 2006 and July 2012. We defined SBBC as bilateral breast tumors diagnosed simultaneously or up to 3 months after initial diagnosis. Clinical data included comorbidities, BMI (kg/m(2)), preoperative breast imaging modalities used and their findings. RESULTS: Of the 2322 patients with newly diagnosed breast cancer treated on the study period, 46 patients with the diagnosis of SBBC were enrolled to the study. A total of 41.3% patients had family history of breast cancer. A total of 56.52% had clinical symptoms. The most frequent situation of diagnosis (32.6%) was the association of a palpable tumor and a contralateral radiologic abnormality. MRI permitted the diagnosis of 19.6% occult contralateral lesions. DISCUSSION AND CONCLUSION: Clinical examination and conventional imaging procedures (mammography and sonography) detects the majority (76%) of synchronous contralateral breast cancers. A family history of breast cancer, a multifocal breast tumor or the presence of an invasive lobular carcinoma should be arguments for the realization of a breat MRI to eliminate contralateral malignancy. CI - Copyright (c) 2013 Elsevier Masson SAS. All rights reserved. FAU - Lebris, A AU - Lebris A AD - Departement de gynecologie, hopital Bretonneau, centre hospitalier regional universitaire de Tours, 2b, boulevard Tonnele, 37044 Tours, France; Faculte de medecine Francois-Rabelais, 37044 Tours, France. FAU - Vilde, A AU - Vilde A AD - Departement de radiologie, hopital Bretonneau, centre hospitalier regional universitaire de Tours, 2b, boulevard Tonnele, 37044 Tours, France. FAU - Marret, H AU - Marret H AD - Departement de gynecologie, hopital Bretonneau, centre hospitalier regional universitaire de Tours, 2b, boulevard Tonnele, 37044 Tours, France; Faculte de medecine Francois-Rabelais, 37044 Tours, France. FAU - Body, G AU - Body G AD - Departement de gynecologie, hopital Bretonneau, centre hospitalier regional universitaire de Tours, 2b, boulevard Tonnele, 37044 Tours, France; Faculte de medecine Francois-Rabelais, 37044 Tours, France. FAU - Ouldamer, L AU - Ouldamer L AD - Departement de gynecologie, hopital Bretonneau, centre hospitalier regional universitaire de Tours, 2b, boulevard Tonnele, 37044 Tours, France; Faculte de medecine Francois-Rabelais, 37044 Tours, France; Unite Inserm 1069, 37044 Tours, France. Electronic address: l.ouldamer@chu-tours.fr. LA - fre PT - English Abstract PT - Journal Article TT - Place de l'imagerie dans le diagnotic des cancers du sein bilateraux synchrones. DEP - 20131203 PL - France TA - Gynecol Obstet Fertil JT - Gynecologie, obstetrique & fertilite JID - 100936305 SB - IM MH - Aged MH - Aged, 80 and over MH - Breast Neoplasms/genetics/*pathology MH - Carcinoma, Lobular/pathology MH - Female MH - France MH - Humans MH - Magnetic Resonance Imaging MH - Mammography MH - Middle Aged MH - Neoplasms, Multiple Primary/genetics/*pathology MH - Risk Factors MH - Ultrasonography, Mammary OTO - NOTNLM OT - Bilateral OT - Bilateral OT - Breast cancer OT - Cancer du sein OT - IRM OT - MRI OT - Mammographie OT - Mammography EDAT- 2013/12/07 06:00 MHDA- 2015/04/07 06:00 CRDT- 2013/12/07 06:00 PHST- 2013/05/03 00:00 [received] PHST- 2013/08/12 00:00 [accepted] PHST- 2013/12/07 06:00 [entrez] PHST- 2013/12/07 06:00 [pubmed] PHST- 2015/04/07 06:00 [medline] AID - S1297-9589(13)00230-0 [pii] AID - 10.1016/j.gyobfe.2013.08.004 [doi] PST - ppublish SO - Gynecol Obstet Fertil. 2014 Jan;42(1):14-9. doi: 10.1016/j.gyobfe.2013.08.004. Epub 2013 Dec 3.